We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
25 hedge funds and large institutions have $9.54M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$768K | |
| 2 | +$298K | |
| 3 | +$278K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$38.9K |
| 5 |
BBPWM
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
|
+$14.8K |
Top Sellers
| 1 | -$2.23M | |
| 2 | -$748K | |
| 3 | -$652K | |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$202K |
| 5 |
Morgan Stanley
New York
|
-$46.3K |